Clinical significance of donor-recipient HLA matching on survival after myeloablative hematopoietic cell transplantation from unrelated donors

Tissue Antigens

Volumn 69, Issue SUPPL. 1, 2007, Pages 25-30

  Petersdorf, E W ^a   Gooley, T ^a   Malkki, M ^a   Horowitz, M ^b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Donor recipient matching; HCT; HLA; Unrelated donor

Indexed keywords

HLA ANTIGEN;

ADOLESCENT; ADULT; AGED; CHILD; CONFERENCE PAPER; DONOR; FEMALE; GENE LOCUS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA MATCHING; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; MYELOABLATIVE CONDITIONING; PRIORITY JOURNAL; RISK ASSESSMENT;

ADOLESCENT; ADULT; AGED; BLOOD DONORS; CHILD; CHILD, PRESCHOOL; DONOR SELECTION; FEMALE; GRAFT SURVIVAL; GRAFT VS HOST DISEASE; HAPLOTYPES; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; INFANT; MALE; MIDDLE AGED; TRANSPLANTATION; TREATMENT OUTCOME;

EID: 34247259667     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2006.759_2.x     Document Type: Conference Paper

References (19)

1. Hurley CK, Baxter-Lowe, LA, Begovich AB et al. The extent of HLA class II allele level disparity in unrelated bone marrow transplantation: analysis of 1259 National Marrow Donor Program donor-recipient pairs. Bone Marrow Transplant 2000: 25: 385-93.
2. Sasazuki T, Juji T, Morishima Y et al. Effect of matching of class I HLAalleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor. N Engl J Med 1998: 339: 1177-85.
3. Petersdorf EW, Kollman C, Hurley CK et al. Effect of HLA class II gene disparity on clinical outcome in unrelated donor hematopoietic cell transplantation for chronic myeloid leukemia: The US National Marrow Donor Program Experience. Blood 2001: 98: 2922-29.
4. Speiser DE, Tiercy JM, Rufer N et al. High resolution HLA matching associated with decreased mortality after unrelated bone marrow transplantation. Blood 1996: 87: 4455-62.
5. Morishima Y, Sasazuki T, Inoko H et al. The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B and HLA-Dr matched unrelated donors. Blood 2002: 99: 4200-6.
6. Flomenberg N, Baxter-Lowe LE, Confer D et al. Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome. Blood 2004: 104: 1923-30.
7. Petersdorf EW, Gooley TA, Anasetti C et al. Optimizing outcome after unrelated marrow transplantation by comprehensive matching of HLA class I and II alleles in the donor and recipient. Blood 1998: 92: 3515-20.
8. Petersdorf EW, Hansen JA, Martin PJ et al. Major histocompatibility complex class I alleles and antigens in hematopoietic cell transplantation. N Engl J Med 2001: 345: 1794-1800.
9. Petersdorf EW, Gooley T, Malkki M, Horowitz M. Impact of donor-recipient HLA matching on survival after myeloablative hematopoietic cell transplantation from unrelated donors. In: Hansen JA, ed. Immunobiology of the Human MHC (Proceedings of the 13th International Histocompatibility Workshop and Conference), Vol. 1. Seattle: IHWG Press, 2007, 1336-47.
10. Petersdorf EW, Anasetti C, Martin PJ et al. Limits of HLA mismatching in unrelated hematopoietic cell transplantation. Blood 2004: 104: 2976-80.
11. Varney MD, Lester S, McCluskey J et al. Matching for HLA DPA1 and DPB1 alleles in unrelated bone marrow transplantation. Hum Immunol 1999: 60: 532-8.
12. Petersdorf EW, Gooley T, Malkki M et al. The biological significance of HLA-DP gene variation in haematopoietic cell transplantation. Brit J Haematol 2001: 112: 988-94.
13. Loiseau P, Espérou H, Busson M et al. DPB1 disparities contribute to severe GVHD and reduced patient survival after unrelated donor bone marrow transplantation. Bone Marrow Transplant 2002: 30: 497-502.
14. Schaffer M, Aldener-Cannavá A, Remberger M et al. Roles of HLA-B, HLA-C and HLA-DPA1 incompatibilities in the outcome of unrelated stem-cell transplantation. Tissue Antigens 2003: 2: 243-50.
15. Shaw BE, Marsh SGE, Mayor NP, Russell NH, Madrigal JA. HLA-DPB1 matching status has significant implications for recipients of unrelated donor stem cell transplants. Blood 2005: 7: 1220-6.
16. Shaw BE, Gooley T, Madrigal JA, Malkki M, Marsh SGE, Petersdorf EW on behalf of the IHWG HCT Component. Clinical importance of HLA-DPB1 in haematopoietic cell transplantation. Tissue Antigens 2007: 69 (Suppl. 1): 36-41.
17. Nagler A, Brautbar C, Slavin S et al. Bone marrow transplantation using unrelated and family related donors: the impact of HLA-C disparity. Bone Marrow Transplant 1996: 18: 891-7.
18. Tiercy J-M, Passweg J, van Biezen A, Zander A et al. Isolated HLA-C mismatches in unrelated donor transplantation for CML. Bone Marrow Transplant 1004: 34: 249-55.
19. Morishima Y, Kawase T, Malkki M, Petersdorf EW on behalf of the International Histocompatibility Working Group in Hematopoietic Cell Transplantation Component. Effect of HLA-A2 allele disparity on clinical outcome in hematopoietic cell transplantation from unrelated donors. Tissue Antigens 2007: 69 (Suppl. 1): 31-5.